N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
Junmei Chen, Adili Reheman, Francisca C Gushiken, Leticia Nolasco, Xiaoyun Fu, Joel L Moake, Heyu Ni, José A López
doi:10.1172/JCI41062.
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by systemic microvascular thrombosis caused by adhesion of platelets to ultra-large vWF (ULVWF) multimers. These multimers accumulate because of a deficiency of the processing enzyme ADAMTS13. vWF protein forms long multimers from homodimers that first form through C-terminal disulfide bonds and then join through their N termini by further disulfide bonding. N-acetylcysteine (NAC) is an FDA-approved drug that has long been used to treat chronic obstructive lung disease and acetaminophen toxicity and is known to function in the former disorder by reducing mucin multimers. Here, we examined whether NAC could reduce vWF multimers, which polymerize in a manner similar to mucins. In vitro, NAC reduced soluble plasma-type vWF multimers in a concentration-dependent manner and rapidly degraded ULVWF multimer strings extruded from activated ECs. The effect was preceded by reduction of the intrachain disulfide bond encompassing the platelet-binding A1 domain. NAC also inhibited vWF-dependent platelet aggregation and collagen binding. Injection of NAC into ADAMTS13-deficient mice led to the rapid resolution of thrombi produced by ionophore treatment of the mesenteric venules and reduced plasma vWF multimers. These results suggest that NAC may be a rapid and effective treatment for patients with TTP.
References
Anfossi, Russo, Massucco, Mattiello, Cavalot et al., N-acetyl-L-cysteine exerts direct antiaggregating effect on human platelets, Eur J Clin Invest
Bernardo, Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation, J Thromb Haemost
Bridges, Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings, Blood
Conway, Pearce, Chin, Hart, Lip, Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation, Circulation
Corcoran, Wong, Role of GSH in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice, J Pharmacol Exp Ther
Cruz, Handin, Wise, The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein, J Biol Chem
Darabi, Berg, Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP, Am J Clin Pathol
Ding, Kim, Dorsam, Kunapuli, Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270, Blood
Dong, ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions, Blood
Favaloro, Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source, Thromb Haemost
Furlan, Lammle, Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease, Best Pract Res Clin Haematol
Furlan, Robles, Lamie, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood
Heard, Acetylcysteine for acetaminophen poisoning, N Engl J Med
Jepsen, Hansen, The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects, Scand J Clin Lab Invest
Johnston, Hawkins, Weikel, The toxicity of N-acetylcysteine in laboratory animals, Semin Oncol
Jollow, Mitchell, Potter, Davis, Gillette et al., Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo, J Pharmacol Exp Ther
Jollow, Thorgeirsson, Potter, Hashimoto, Mitchell, Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen, Pharmacology
Kaul, Nagel, Chen, Tsai, Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion, Blood
Kelly, Clinical applications of N-acetylcysteine, Altern Med Rev
Knudsen, Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects, Gut
Lauterburg, Corcoran, Mitchell, Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo, J Clin Invest
Li, Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions, J Thromb Haemost
Li, Moake, Mcintire, Characterization of von Willebrand factor interaction with collagens in real time using surface plasmon resonance, Ann Biomed Eng
Lian, Harkness, Byrnes, Wallach, Nunez, Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma, Blood
Lopez, Malignant malaria and microangiopathies: merging mechanisms, Blood
Loscalzo, N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin, J Clin Invest
Miller, Rumack, Clinical safety of high oral doses of acetylcysteine, Semin Oncol
Mitchell, Jollow, Potter, Gillette, Brodie, Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione, J Pharmacol Exp Ther
Moake, Turner, Stathopoulos, Nolasco, Hellums, Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation, J Clin Invest
Moake, Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura, N Engl J Med
Ni, Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen, J Clin Invest
Nolasco, Hemolytic uremic syndromeassociated Shiga toxins promote endothelialcell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers, Blood
Palmer, S-nitrosothiols signal hypoxiamimetic vascular pathology, J Clin Invest
Perez-Vilar, Hill, The structure and assembly of secreted mucins, J Biol Chem
Potter, Thorgeirsson, Jollow, Mitchell, Acetaminophen-induced hepatic necrosis. V. Cor-relation of hepatic necrosis, covalent binding and glutathione depletion in hamsters, Pharmacology
Reheman, Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor, Blood
Reheman, Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation, J Thromb Haemost
Sadler, Biochemistry and genetics of von Willebrand factor, Annu Rev Biochem
Savi, The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts, Proc Natl Acad Sci U S A
Sheffner, Medler, Jacobs, Sarett, The in vitro reduction in viscosity of human tracheobronchial secretions by acetylcysteine, Am Rev Respir Dis
Spiel, Gilbert, Jilma, von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes, Circulation
Tsai, Current concepts in thrombotic thrombocytopenic purpura, Annu Rev Med
Tsai, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood
Vesely, ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients, Blood
Vischer, Wagner, von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies, Blood
Wick, Moake, Udden, Eskin, Sears et al., Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow, J Clin Invest
Wijeysundera, N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery, Crit Care Med
DOI record:
{
"DOI": "10.1172/jci41062",
"ISSN": [
"0021-9738"
],
"URL": "http://dx.doi.org/10.1172/JCI41062",
"author": [
{
"affiliation": [],
"family": "Chen",
"given": "Junmei",
"sequence": "first"
},
{
"affiliation": [],
"family": "Reheman",
"given": "Adili",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Gushiken",
"given": "Francisca C.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Nolasco",
"given": "Leticia",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Fu",
"given": "Xiaoyun",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Moake",
"given": "Joel L.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ni",
"given": "Heyu",
"sequence": "additional"
},
{
"affiliation": [],
"family": "López",
"given": "José A.",
"sequence": "additional"
}
],
"container-title": "Journal of Clinical Investigation",
"container-title-short": "J. Clin. Invest.",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2011,
1,
25
]
],
"date-time": "2011-01-25T16:38:52Z",
"timestamp": 1295973532000
},
"deposited": {
"date-parts": [
[
2025,
3,
2
]
],
"date-time": "2025-03-02T04:41:00Z",
"timestamp": 1740890460000
},
"indexed": {
"date-parts": [
[
2025,
9,
29
]
],
"date-time": "2025-09-29T20:32:10Z",
"timestamp": 1759177930916,
"version": "3.38.0"
},
"is-referenced-by-count": 191,
"issue": "2",
"issued": {
"date-parts": [
[
2011,
2,
1
]
]
},
"journal-issue": {
"issue": "2",
"published-print": {
"date-parts": [
[
2011,
2,
1
]
]
}
},
"language": "en",
"link": [
{
"URL": "http://www.jci.org/articles/view/41062/files/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "232",
"original-title": [],
"page": "593-603",
"prefix": "10.1172",
"published": {
"date-parts": [
[
2011,
2,
1
]
]
},
"published-print": {
"date-parts": [
[
2011,
2,
1
]
]
},
"publisher": "American Society for Clinical Investigation",
"reference": [
{
"DOI": "10.1146/annurev.med.57.061804.084505",
"doi-asserted-by": "publisher",
"key": "B1"
},
{
"DOI": "10.1182/blood.V53.2.333.333",
"author": "Lian",
"doi-asserted-by": "crossref",
"first-page": "333",
"journal-title": "Blood.",
"key": "B2",
"volume": "53",
"year": "1979"
},
{
"DOI": "10.1056/NEJM198212023072306",
"doi-asserted-by": "publisher",
"key": "B3"
},
{
"DOI": "10.1172/JCI112736",
"doi-asserted-by": "publisher",
"key": "B4"
},
{
"DOI": "10.1114/1.1521931",
"doi-asserted-by": "publisher",
"key": "B5"
},
{
"DOI": "10.1172/JCI113151",
"doi-asserted-by": "publisher",
"key": "B6"
},
{
"DOI": "10.1182/blood.V87.10.4223.bloodjournal87104223",
"author": "Furlan",
"doi-asserted-by": "crossref",
"first-page": "4223",
"journal-title": "Blood.",
"key": "B7",
"volume": "87",
"year": "1996"
},
{
"DOI": "10.1182/blood.V87.10.4235.bloodjournal87104235",
"author": "Tsai",
"doi-asserted-by": "crossref",
"first-page": "4235",
"journal-title": "Blood.",
"key": "B8",
"volume": "87",
"year": "1996"
},
{
"DOI": "10.1309/RLNM-J01W-BJRN-LH03",
"author": "Darabi",
"doi-asserted-by": "crossref",
"first-page": "592",
"journal-title": "Am J Clin Pathol.",
"key": "B9",
"volume": "125",
"year": "2006"
},
{
"DOI": "10.1146/annurev.biochem.67.1.395",
"doi-asserted-by": "publisher",
"key": "B10"
},
{
"DOI": "10.1182/blood.V83.12.3536.3536",
"author": "Vischer",
"doi-asserted-by": "crossref",
"first-page": "3536",
"journal-title": "Blood.",
"key": "B11",
"volume": "83",
"year": "1994"
},
{
"DOI": "10.1074/jbc.274.45.31751",
"author": "Perez-Vilar",
"doi-asserted-by": "crossref",
"first-page": "31751",
"journal-title": "J Biol Chem.",
"key": "B12",
"volume": "274",
"year": "1999"
},
{
"author": "Kelly",
"first-page": "114",
"journal-title": "Altern Med Rev.",
"key": "B13",
"volume": "3",
"year": "1998"
},
{
"author": "Sheffner",
"first-page": "721",
"journal-title": "Am Rev Respir Dis.",
"key": "B14",
"volume": "90",
"year": "1964"
},
{
"DOI": "10.1016/S0021-9258(19)36916-9",
"author": "Cruz",
"doi-asserted-by": "crossref",
"first-page": "21238",
"journal-title": "J Biol Chem.",
"key": "B15",
"volume": "268",
"year": "1993"
},
{
"DOI": "10.1056/NEJMct0708278",
"doi-asserted-by": "publisher",
"key": "B16"
},
{
"DOI": "10.1136/gut.2004.043505",
"doi-asserted-by": "publisher",
"key": "B17"
},
{
"DOI": "10.1172/JCI112024",
"doi-asserted-by": "publisher",
"key": "B18"
},
{
"DOI": "10.1046/j.1365-2362.2001.00815.x",
"doi-asserted-by": "publisher",
"key": "B19"
},
{
"DOI": "10.1182/blood-2002-10-3027",
"doi-asserted-by": "publisher",
"key": "B20"
},
{
"DOI": "10.1073/pnas.0510446103",
"doi-asserted-by": "publisher",
"key": "B21"
},
{
"DOI": "10.1111/j.1538-7836.2004.00661.x",
"doi-asserted-by": "publisher",
"key": "B22"
},
{
"DOI": "10.1016/S0022-3565(25)25048-0",
"author": "Corcoran",
"doi-asserted-by": "crossref",
"first-page": "54",
"journal-title": "J Pharmacol Exp Ther.",
"key": "B23",
"volume": "238",
"year": "1986"
},
{
"DOI": "10.1159/000136547",
"doi-asserted-by": "publisher",
"key": "B24"
},
{
"DOI": "10.1016/S0022-3565(25)29664-1",
"author": "Jollow",
"doi-asserted-by": "crossref",
"first-page": "195",
"journal-title": "J Pharmacol Exp Ther.",
"key": "B25",
"volume": "187",
"year": "1973"
},
{
"DOI": "10.1016/S0022-3565(25)29666-5",
"author": "Mitchell",
"doi-asserted-by": "crossref",
"first-page": "211",
"journal-title": "J Pharmacol Exp Ther.",
"key": "B26",
"volume": "187",
"year": "1973"
},
{
"DOI": "10.1159/000136531",
"doi-asserted-by": "publisher",
"key": "B27"
},
{
"DOI": "10.1172/JCI110853",
"doi-asserted-by": "publisher",
"key": "B28"
},
{
"DOI": "10.1053/beha.2001.0142",
"doi-asserted-by": "publisher",
"key": "B29"
},
{
"DOI": "10.1111/j.1538-7836.2008.02991.x",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "1135",
"journal-title": "J Thromb Haemost.",
"key": "B30",
"volume": "6",
"year": "2008"
},
{
"author": "Miller",
"first-page": "76",
"journal-title": "Semin Oncol.",
"key": "B31",
"volume": "10",
"year": "1983"
},
{
"author": "Johnston",
"first-page": "17",
"journal-title": "Semin Oncol.",
"key": "B32",
"volume": "10",
"year": "1983"
},
{
"DOI": "10.1172/JCI29444",
"author": "Palmer",
"doi-asserted-by": "crossref",
"first-page": "2592",
"journal-title": "J Clin Invest.",
"key": "B33",
"volume": "117",
"year": "2007"
},
{
"DOI": "10.3109/00365519409088566",
"doi-asserted-by": "publisher",
"key": "B34"
},
{
"DOI": "10.1097/CCM.0b013e31819ffed4",
"doi-asserted-by": "publisher",
"key": "B35"
},
{
"DOI": "10.1182/blood-2003-01-0193",
"doi-asserted-by": "publisher",
"key": "B36"
},
{
"DOI": "10.1182/blood.V81.9.2429.2429",
"author": "Kaul",
"doi-asserted-by": "crossref",
"first-page": "2429",
"journal-title": "Blood.",
"key": "B37",
"volume": "81",
"year": "1993"
},
{
"DOI": "10.1161/CIRCULATIONAHA.107.722827",
"doi-asserted-by": "publisher",
"key": "B38"
},
{
"DOI": "10.1182/blood-2009-07-235150",
"doi-asserted-by": "publisher",
"key": "B39"
},
{
"DOI": "10.1182/blood-2009-12-254060",
"author": "Lopez",
"doi-asserted-by": "crossref",
"first-page": "1317",
"journal-title": "Blood.",
"key": "B40",
"volume": "115",
"year": "2010"
},
{
"DOI": "10.1161/01.CIR.0000077912.12202.FC",
"doi-asserted-by": "publisher",
"key": "B41"
},
{
"DOI": "10.1182/blood-2005-05-2111",
"doi-asserted-by": "publisher",
"key": "B42"
},
{
"DOI": "10.1182/blood-2002-05-1401",
"doi-asserted-by": "publisher",
"key": "B43"
},
{
"DOI": "10.1055/s-0037-1613768",
"author": "Favaloro",
"doi-asserted-by": "crossref",
"first-page": "127",
"journal-title": "Thromb Haemost.",
"key": "B44",
"volume": "83",
"year": "2000"
},
{
"DOI": "10.1172/JCI9896",
"doi-asserted-by": "publisher",
"key": "B45"
},
{
"DOI": "10.1111/j.1538-7836.2005.01217.x",
"doi-asserted-by": "publisher",
"key": "B46"
},
{
"DOI": "10.1182/blood-2008-04-148361",
"doi-asserted-by": "publisher",
"key": "B47"
}
],
"reference-count": 47,
"references-count": 47,
"relation": {
"has-review": [
{
"asserted-by": "object",
"id": "10.3410/f.8480966.8950065",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.3410/f.8480966.13928055",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.3410/f.8480966.10431054",
"id-type": "doi"
}
]
},
"resource": {
"primary": {
"URL": "http://www.jci.org/articles/view/41062"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice",
"type": "journal-article",
"volume": "121"
}
